FENNEC PHARMACEUTICALS INC. Earnings Per Share Diluted

Quick Answer

FENNEC PHARMACEUTICALS INC. reported Earnings Per Share Diluted of $0.34 (loss) per share for the year ending 2025.

  • FENNEC PHARMACEUTICALS INC. showed a decrease of -1,600.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2011: $0.19 per share | Q1 2012: $0.11 per share | Q1 2014: $0.33 (loss) per share | Q2 2014: $0.08 (loss) per share | Q3 2014: $0.03 per share | Q1 2015: $0.01 per share | Q2 2015: $0.02 (loss) per share | Q3 2015: $0.01 (loss) per share | Q1 2016: $0.04 (loss) per share | Q2 2016: $0.06 (loss) per share | Q3 2016: $0.04 (loss) per share | Q1 2017: $0.06 (loss) per share | Q2 2017: $0.11 (loss) per share | Q3 2017: $0.15 (loss) per share | Q1 2018: $0.09 (loss) per share | Q2 2018: $0.14 (loss) per share | Q3 2018: $0.14 (loss) per share | Q1 2019: $0.14 per share | Q2 2019: $0.24 (loss) per share | Q3 2019: $0.09 (loss) per share | Q1 2020: $0.19 (loss) per share | Q2 2020: $0.21 (loss) per share | Q3 2020: $0.24 (loss) per share | Q1 2021: $0.18 (loss) per share | Q2 2021: $0.15 (loss) per share | Q3 2021: $0.16 (loss) per share | Q1 2022: $0.14 (loss) per share | Q2 2022: $0.19 (loss) per share | Q3 2022: $0.31 (loss) per share | Q1 2023: $0.23 (loss) per share | Q2 2023: $0.21 (loss) per share | Q3 2023: $0.07 (loss) per share | Q1 2024: $0.41 per share | Q2 2024: $0.20 (loss) per share | Q3 2024: $0.21 (loss) per share | Q1 2025: $0.04 (loss) per share | Q2 2025: $0.11 (loss) per share | Q3 2025: $0.02 (loss) per share.
  • Over the full 11 years of available data (2010 to 2025), FENNEC PHARMACEUTICALS INC.'s Earnings Per Share Diluted has grown by 30.6%.
  • Historical annual values: Fiscal year 2025: $0.34 (loss) per share | Fiscal year 2024: $0.02 (loss) per share | Fiscal year 2023: $0.60 (loss) per share | Fiscal year 2022: $0.90 (loss) per share | Fiscal year 2021: $0.67 (loss) per share | Fiscal year 2020: $0.76 (loss) per share | Fiscal year 2014: $0.22 (loss) per share | Fiscal year 2013: $0.17 per share | Fiscal year 2012: $0.21 (loss) per share | Fiscal year 2011: $0.19 per share | Fiscal year 2010: $0.49 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: